Editorial
Nuevos anticoagulantes orales: controversias y retos
New oral anticoagulants: Disputes and challenges
Francisco Cabrera-Buenoa,
, Antonio Muñoz-Garcíaa, Nieves Romero-Rodríguezb, Eduardo Arana-Ruedab, Manuel Jiménez-Navarroa
Autor para correspondencia
a UGC del Corazón, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Clínico Universitario Virgen de la Victoria, Universidad de Málaga, Málaga, España
b UGC del Corazón, Instituto de Biomedicina de Sevilla (IBIS), Hospital Universitario Virgen del Rocío, Universidad de Sevilla, Sevilla, España
Leído
2854
Vecesse ha leído el artículo
797
Total PDF
2057
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 7 | 5 | 12 |
| 2025 11 | 20 | 12 | 32 |
| 2025 10 | 22 | 7 | 29 |
| 2025 9 | 11 | 8 | 19 |
| 2025 8 | 17 | 9 | 26 |
| 2025 7 | 15 | 4 | 19 |
| 2025 6 | 14 | 1 | 15 |
| 2025 5 | 22 | 2 | 24 |
| 2025 4 | 8 | 2 | 10 |
| 2025 3 | 17 | 6 | 23 |
| 2025 2 | 37 | 0 | 37 |
| 2025 1 | 34 | 3 | 37 |
| 2024 12 | 12 | 1 | 13 |
| 2024 11 | 14 | 2 | 16 |
| 2024 10 | 11 | 2 | 13 |
| 2024 9 | 14 | 3 | 17 |
| 2024 8 | 12 | 3 | 15 |
| 2024 7 | 15 | 2 | 17 |
| 2024 6 | 8 | 2 | 10 |
| 2024 5 | 22 | 4 | 26 |
| 2024 4 | 12 | 4 | 16 |
| 2024 3 | 14 | 4 | 18 |
| 2024 2 | 16 | 6 | 22 |
| 2024 1 | 13 | 5 | 18 |
| 2023 12 | 8 | 8 | 16 |
| 2023 11 | 13 | 3 | 16 |
| 2023 10 | 11 | 8 | 19 |
| 2023 9 | 9 | 2 | 11 |
| 2023 8 | 18 | 3 | 21 |
| 2023 7 | 12 | 8 | 20 |
| 2023 6 | 9 | 1 | 10 |
| 2023 5 | 42 | 5 | 47 |
| 2023 4 | 35 | 1 | 36 |
| 2023 3 | 14 | 2 | 16 |
| 2023 2 | 13 | 2 | 15 |
| 2022 1 | 8 | 4 | 12 |
| 2022 12 | 15 | 3 | 18 |
| 2022 11 | 17 | 7 | 24 |
| 2022 10 | 17 | 5 | 22 |
| 2022 9 | 12 | 14 | 26 |
| 2022 8 | 11 | 3 | 14 |
| 2022 7 | 13 | 9 | 22 |
| 2022 6 | 11 | 4 | 15 |
| 2022 5 | 11 | 5 | 16 |
| 2022 4 | 14 | 6 | 20 |
| 2022 3 | 17 | 6 | 23 |
| 2022 2 | 16 | 8 | 24 |
| 2021 1 | 21 | 9 | 30 |
| 2021 12 | 15 | 7 | 22 |
| 2021 11 | 11 | 5 | 16 |
| 2021 10 | 24 | 11 | 35 |
| 2021 9 | 12 | 6 | 18 |
| 2021 8 | 8 | 2 | 10 |
| 2021 7 | 7 | 7 | 14 |
| 2021 6 | 15 | 6 | 21 |
| 2021 5 | 16 | 4 | 20 |
| 2021 4 | 50 | 21 | 71 |
| 2021 3 | 29 | 6 | 35 |
| 2021 2 | 10 | 4 | 14 |
| 2020 1 | 17 | 18 | 35 |
| 2020 12 | 19 | 10 | 29 |
| 2020 11 | 7 | 6 | 13 |
| 2020 10 | 13 | 6 | 19 |
| 2020 9 | 9 | 9 | 18 |
| 2020 8 | 9 | 8 | 17 |
| 2020 7 | 14 | 5 | 19 |
| 2020 6 | 13 | 6 | 19 |
| 2020 5 | 7 | 12 | 19 |
| 2020 4 | 3 | 5 | 8 |
| 2020 3 | 3 | 0 | 3 |
| 2019 1 | 1 | 2 | 3 |
| 2018 7 | 1 | 0 | 1 |
| 2018 5 | 1 | 1 | 2 |
| 2018 4 | 8 | 1 | 9 |
| 2018 3 | 10 | 0 | 10 |
| 2018 2 | 5 | 0 | 5 |
| 2018 1 | 11 | 0 | 11 |
| 2017 12 | 9 | 1 | 10 |
| 2017 11 | 8 | 5 | 13 |
| 2017 10 | 14 | 2 | 16 |
| 2017 9 | 14 | 9 | 23 |
| 2017 8 | 6 | 4 | 10 |
| 2017 7 | 15 | 1 | 16 |
| 2017 6 | 14 | 25 | 39 |
| 2017 5 | 26 | 12 | 38 |
| 2017 4 | 22 | 16 | 38 |
| 2017 3 | 34 | 28 | 62 |
| 2017 2 | 19 | 3 | 22 |
| 2016 1 | 15 | 2 | 17 |
| 2016 12 | 29 | 8 | 37 |
| 2016 11 | 47 | 8 | 55 |
| 2016 10 | 54 | 11 | 65 |
| 2016 9 | 41 | 5 | 46 |
| 2016 8 | 31 | 4 | 35 |
| 2016 7 | 22 | 1 | 23 |
| 2016 6 | 30 | 17 | 47 |
| 2016 5 | 26 | 21 | 47 |
| 2016 4 | 27 | 13 | 40 |
| 2016 3 | 24 | 18 | 42 |
| 2016 2 | 32 | 19 | 51 |
| 2015 1 | 16 | 14 | 30 |
| 2015 12 | 24 | 8 | 32 |
| 2015 11 | 22 | 18 | 40 |
| 2015 10 | 28 | 14 | 42 |
| 2015 9 | 20 | 15 | 35 |
| 2015 8 | 43 | 12 | 55 |
| 2015 7 | 27 | 10 | 37 |
| 2015 6 | 26 | 14 | 40 |
| 2015 5 | 40 | 8 | 48 |
| 2015 4 | 44 | 17 | 61 |
| 2015 3 | 29 | 7 | 36 |
| 2015 2 | 22 | 18 | 40 |
| 2015 1 | 35 | 12 | 47 |
| 2014 12 | 7 | 2 | 9 |
| 2014 11 | 9 | 1 | 10 |
| 2014 9 | 3 | 1 | 4 |
| 2014 8 | 1 | 2 | 3 |
Mostrar todo
